Aspire Biopharma Holdings, Inc. - Common Stock (ASBP)
CUSIP: 738920107
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 138,530,928
- Total 13F shares
- 1,435,984
- Share change
- +1,435,984
- Total reported value
- $875,750
- Price per share
- $0.58
- Number of holders
- 15
- Value change
- +$875,750
- Number of buys
- 15
Quarterly Holders Quick Answers
What is CUSIP 738920107?
CUSIP 738920107 identifies ASBP - Aspire Biopharma Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q2 2025
Recent filing periods for CUSIP 738920107:
Top shareholders of ASBP - Aspire Biopharma Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Harraden Circle Investments, LLC |
13D/G
|
— |
0.31%
|
150,000
|
$70,500 | $0 | 31 Mar 2025 | |
| Surendra K. Ajjarapu |
3/4/5
|
Chief Executive Officer, Director, 10%+ Owner |
—
class O/S missing
|
4,317,500
|
— | — | 18 Aug 2023 | |
| PowerUp Sponsor LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,870,000
|
— | — | 18 Aug 2023 |
Institutional Holders of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) as of Q1 2025
As of 31 Mar 2025,
Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,435,984 shares.
The largest 10 holders included
TORONTO DOMINION BANK, Crewe Advisors LLC, Harraden Circle Investments, LLC, Optivise Advisory Services LLC, Procyon Advisors, LLC, Periscope Capital Inc., Platform Technology Partners, UBS Group AG, TWO SIGMA SECURITIES, LLC, and CITADEL ADVISORS LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q3 2025 Across Filers
Q3 2025 holders
25
Q1 2025 holders
15
Holder diff
-10
| Investor | Q3 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.